Obesity Trials in Auckland, New Zealand
Conditions / Obesity / Auckland, New Zealand
Obesity is a medical condition with active clinical research programs worldwide.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05822544 | Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes | RECRUITING | PHASE1 |
| NCT06077864 | A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) | ACTIVE_NOT_RECRUITING | — |
| NCT04667377 | A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight | COMPLETED | PHASE2 |
| NCT07284875 | Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes | RECRUITING | — |
| NCT06937203 | Study of ARO-ALK7 in Adult Volunteers With Obesity With and Without Type 2 Diabetes Mellitus | RECRUITING | PHASE1/PHASE2 |
| NCT06053216 | Indirect Calorimetry Guided Energy Provision in Critically Ill Patients With Obesity | RECRUITING | NA |
| NCT01486680 | Silastic Ring Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Obese Patients | COMPLETED | NA |
| NCT05296733 | A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906 | COMPLETED | PHASE1 |
| NCT05616013 | Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese | COMPLETED | PHASE2 |
| NCT02019264 | A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors | COMPLETED | PHASE4 |